A novel eye-tracking digital marker outperforms plasma biomarkers in detecting cognitive impairment - PubMed
4 days ago
- #Alzheimer's disease
- #cognitive impairment
- #digital biomarker
- A novel eye-tracking digital marker outperforms plasma biomarkers in detecting cognitive impairment.
- Study involved 119 cognitively unimpaired (CU) individuals and 157 cognitively impaired (CI) patients who underwent digital eye-tracking tests and cognitive scales.
- Eye-tracking panel showed better performance (AUC = 0.865) compared to plasma biomarkers like Aβ42/40 (AUC = 0.699), p-Tau217 (AUC = 0.769), and others.
- Findings validate digital eye-tracking markers as effective for screening cognitive impairment in older adults.
- Research highlights potential of eye-tracking as a novel digital biomarker for Alzheimer's disease and cognitive decline.